Emyria Limited logo

Emyria Limited

ASX:EMD.AX

Overview | Financials
Company Name Emyria Limited
Symbol EMD.AX
Currency AUD
Price 0.052
Market Cap 21,267,428
Dividend Yield 0%
52-week-range 0.04 - 0.129
Industry Health Information Services
Sector Healthcare
CEO Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D.
Website https://emyria.com

An error occurred while fetching data.

About Emyria Limited

Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The

Related Stocks

MedAdvisor Limited logo

MedAdvisor Limited

MDR.AX

0.55 AUD

Orthocell Limited logo

Orthocell Limited

OCC.AX

0.395 AUD

Biotron Limited logo

Biotron Limited

BIT.AX

0.033 AUD

Micro-X Limited logo

Micro-X Limited

MX1.AX

0.079 AUD

Invion Limited logo

Invion Limited

IVX.AX

0.004 AUD

Doctor Care Anywhere Group PLC logo

Doctor Care Anywhere Group PLC

DOC.AX

0.067 AUD

CleanSpace Holdings Limited logo

CleanSpace Holdings Limited

CSX.AX

0.25 AUD

Microba Life Sciences Limited logo

Microba Life Sciences Limited

MAP.AX

0.175 AUD

Antisense Therapeutics Limited logo

Antisense Therapeutics Limited

ANP.AX

0.058 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD